David Bruce
About
David Bruce is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Physiology.
According to data from OpenAlex, David Bruce has authored 190 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Psychiatry and Mental health and 32 papers in Physiology. Recurrent topics in David Bruce's work include Diabetes Management and Research (32 papers), Dementia and Cognitive Impairment Research (26 papers) and Diabetes Management and Education (25 papers). David Bruce is often cited by papers focused on Diabetes Management and Research (32 papers), Dementia and Cognitive Impairment Research (26 papers) and Diabetes Management and Education (25 papers). David Bruce collaborates with scholars based in Australia, United States and United Kingdom. David Bruce's co-authors include Timothy M. E. Davis, Wendy A. Davis, Donald J. Chisholm, Sergio Starkstein, Leonard H Storlien, Richard L. Prince, Amanda Devine, Edward W. Kraegen, Glenn Ford and Wendy S. Pascoe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and SHILAP Revista de lepidopterología.
In The Last Decade
David Bruce
182 papers receiving 7.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| David Bruce Australia | 49 | 2.5k | 1.6k | 1.1k | 1.1k | 999 | 190 | 7.7k | ||
| Bu B. Yeap Australia | 52 | 4.0k 1.6× | 1.3k 0.8× | 879 0.8× | 564 0.5× | 1.5k 1.5× | 299 | 8.8k | ||
| Katherine Samaras Australia | 47 | 1.3k 0.5× | 1.7k 1.1× | 724 0.7× | 1.5k 1.4× | 1.4k 1.4× | 132 | 10.3k | ||
| Majon Muller Netherlands | 45 | 1.6k 0.6× | 1.7k 1.0× | 1.0k 0.9× | 579 0.5× | 1.1k 1.1× | 165 | 6.5k | ||
| Anne M. Murray United States | 43 | 950 0.4× | 1.5k 0.9× | 1.5k 1.3× | 1.3k 1.2× | 836 0.8× | 194 | 9.0k | ||
| Rebecca M. Reynolds United Kingdom | 58 | 2.1k 0.8× | 1.8k 1.1× | 619 0.6× | 1.3k 1.2× | 1.2k 1.2× | 285 | 12.9k | ||
| Jackie F. Price United Kingdom | 50 | 1.8k 0.7× | 1.7k 1.1× | 688 0.6× | 1.3k 1.2× | 1.1k 1.1× | 185 | 10.4k | ||
| Fabio Facchinetti Italy | 54 | 1.6k 0.6× | 1.9k 1.2× | 1.8k 1.6× | 878 0.8× | 1.1k 1.1× | 594 | 12.4k | ||
| Jane B. Shofer United States | 38 | 1.6k 0.6× | 1.1k 0.7× | 511 0.5× | 859 0.8× | 467 0.5× | 93 | 5.5k | ||
| Jordan D. Tobin United States | 41 | 3.3k 1.3× | 1.7k 1.1× | 570 0.5× | 456 0.4× | 1.5k 1.5× | 59 | 8.4k | ||
| Richard I. G. Holt United Kingdom | 47 | 5.4k 2.1× | 1.3k 0.8× | 2.2k 2.0× | 2.0k 1.9× | 756 0.8× | 260 | 9.6k |
Countries citing papers authored by David Bruce
Since
Specialization
Citations
This map shows the geographic impact of David Bruce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bruce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bruce more than expected).
Fields of papers citing papers by David Bruce
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by David Bruce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bruce. The network helps show where David Bruce may publish in the future.
Co-authorship network of co-authors of David Bruce
This figure shows the co-authorship network connecting the top 25 collaborators of David Bruce. A scholar is included among the top collaborators of David Bruce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bruce. David Bruce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Davis, Timothy M. E., et al.. (2024). The inter-relationship between Helicobacter pylori infection, dementia and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase I. Journal of Diabetes and its Complications. 38(11). 108854–108854.
2.
Bruce, David, Wendy A. Davis, & Timothy M. E. Davis. (2023). Group-Based Trajectory Modelling of Changes in Mobility over Six Years in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. Journal of Clinical Medicine. 12(13). 4528–4528.
3.
Davis, Wendy A., David Bruce, Timothy M. E. Davis, & Sergio Starkstein. (2023). The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase II. Journal of Clinical Medicine. 12(24). 7722–7722.
4.
Hunter, Michael, Matthew Knuiman, Arthur W. Musk, et al.. (2021). Prevalence and patterns of multimorbidity in Australian baby boomers: the Busselton healthy ageing study. BMC Public Health. 21(1). 1539–1539.
5.
Drinkwater, Jocelyn J., et al.. (2020). Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II. Cardiovascular Diabetology. 19(1). 43–43.
6.
Davis, Wendy A., David Bruce, Milan Dragović, Timothy M. E. Davis, & Sergio Starkstein. (2018). The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II. PLoS ONE. 13(3). e0194417–e0194417.
7.
Bruce, David, Wendy A. Davis, & Timothy M. E. Davis. (2018). Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetes Obesity and Metabolism. 20(12). 2852–2859.
8.
Bruce, David, Wendy A. Davis, Sergio Starkstein, & Timothy M. E. Davis. (2018). Clinical risk factors for depressive syndrome in Type 2 diabetes: the Fremantle Diabetes Study. Diabetic Medicine. 35(7). 903–910.
9.
Bruce, David, Sergio Starkstein, Wendy A. Davis, et al.. (2017). Depression symptoms are persistent in Type 2 diabetes: risk factors and outcomes of 5‐year depression trajectories using latent class growth analysis. Diabetic Medicine. 34(8). 1108–1115.
10.
Hunter, Michael, et al.. (2017). Anemia complicating type 2 diabetes: Prevalence, risk factors and prognosis. Journal of Diabetes and its Complications. 31(7). 1169–1174.
11.
Hamilton, Emma, Wendy A. Davis, David Bruce, & Timothy M. E. Davis. (2016). Influence of Premature Mortality on the Link Between Type 2 Diabetes and Hip Fracture: The Fremantle Diabetes Study. The Journal of Clinical Endocrinology & Metabolism. 102(2). 551–559.
12.
Davis, Timothy M. E., David Bruce, Sergio Starkstein, et al.. (2015). Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: The Fremantle Diabetes Study Phase II. Diabetes Research and Clinical Practice. 107(3). 384–391.
13.
Starkstein, Sergio, et al.. (2014). Diagnostic Criteria for Depression in Type 2 Diabetes: A Data-Driven Approach. PLoS ONE. 9(11). e112049–e112049.
14.
Hirsch, Ann M., David Bruce, Olga Chertkov, et al.. (2013). Complete Genome Sequence of Micromonospora Strain L5, a Potential Plant-Growth-Regulating Actinomycete, Originally Isolated from Casuarina equisetifolia Root Nodules. Genome Announcements. 1(5).
15.
Skinner, Timothy, David Bruce, Timothy M. E. Davis, & Wendy A. Davis. (2013). Personality traits, self‐care behaviours and glycaemic control in Type 2 diabetes: The Fremantle Diabetes Study Phase II . Diabetic Medicine. 31(4). 487–492.
16.
Starkstein, Sergio, et al.. (2010). Anosognosia Is a Significant Predictor of Apathy in Alzheimer's Disease. Journal of Neuropsychiatry. 22(4). 378–383.
17.
Mwangi, Michael, Shang Wei Wu, Yanjiao Zhou, et al.. (2007). Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proceedings of the National Academy of Sciences. 104(22). 9451–9456.
18.
Bruce, David, Wendy A. Davis, Sergio Starkstein, et al.. (2007). Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 51(2). 241–248.
19.
Bruce, David & Alison M. Paterson. (2000). Barriers to community support for the dementia carer: a qualitative study. International Journal of Geriatric Psychiatry. 15(5). 451–457.
20.
Bruce, David, Donald J. Chisholm, Leonard H Storlien, Edward W. Kraegen, & George A. Smythe. (1992). The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35(9). 835–843.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Bu B. Yeap Breakdown of academic impact, for papers by Katherine Samaras Breakdown of academic impact, for papers by Majon Muller Breakdown of academic impact, for papers by Anne M. Murray Breakdown of academic impact, for papers by Rebecca M. Reynolds Breakdown of academic impact, for papers by Jackie F. Price Breakdown of academic impact, for papers by Fabio Facchinetti Breakdown of academic impact, for papers by Jane B. Shofer Breakdown of academic impact, for papers by Jordan D. Tobin Breakdown of academic impact, for papers by Richard I. G. Holt